These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21598212)

  • 1. TP53 codon 72 polymorphism and P53 protein expression in colorectal cancer specimens in Isfahan.
    Dastjerdi MN
    Acta Med Iran; 2011; 49(2):71-7. PubMed ID: 21598212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the p53 codon 72 polymorphism with clinicopathological characteristics of colorectal cancer through mRNA analysis.
    De Oliveira LP; López I; Dos Santos EM; Tucci P; Marín M; Soares FA; Rossi BM; Coudry Rde A
    Oncol Rep; 2014 Mar; 31(3):1396-406. PubMed ID: 24366026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 R72P and MDM2 SNP309 polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.
    Joshi AM; Budhathoki S; Ohnaka K; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y
    Jpn J Clin Oncol; 2011 Feb; 41(2):232-8. PubMed ID: 21051533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of the genetic polymorphism of p53 (codon 72) gene in colorectal cancer].
    Lima JM; Serafim PV; Silva ID; Forones NM
    Arq Gastroenterol; 2006; 43(1):8-13. PubMed ID: 16699611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy.
    Godai TI; Suda T; Sugano N; Tsuchida K; Shiozawa M; Sekiguchi H; Sekiyama A; Yoshihara M; Matsukuma S; Sakuma Y; Tsuchiya E; Kameda Y; Akaike M; Miyagi Y
    BMC Cancer; 2009 Dec; 9():420. PubMed ID: 19954513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population.
    Song HR; Kweon SS; Kim HN; Piao JM; Yun WJ; Choi JS; Hwang JE; Yoon JY; Kim HR; Park YK; Kim SH; Choi YD; Shin MH
    Gastric Cancer; 2011 Aug; 14(3):242-8. PubMed ID: 21461655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases.
    Chen RH; Chang CT; Wang TY; Huang WL; Tsai CH; Tsai FJ
    J Clin Lab Anal; 2008; 22(5):321-6. PubMed ID: 18803266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population.
    Zhu ZZ; Wang AZ; Jia HR; Jin XX; He XL; Hou LF; Zhu G
    Jpn J Clin Oncol; 2007 May; 37(5):385-90. PubMed ID: 17599946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina.
    Pérez LO; Abba MC; Dulout FN; Golijow CD
    World J Gastroenterol; 2006 Mar; 12(9):1426-9. PubMed ID: 16552814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p 53 codon 72 polymorphism in stomach and colorectal adenocarcinomas in Iranian patients.
    Mojtahedi Z; Haghshenas MR; Hosseini SV; Fattahi MJ; Ghaderi A
    Indian J Cancer; 2010; 47(1):31-4. PubMed ID: 20071787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of P53 codon 72 polymorphism and lung cancer in an ethnic Iranian population.
    Eydian Z; Asna'ashari AM; Behravan J; Sharifi-Rad J; Entezari Heravi R
    Cell Mol Biol (Noisy-le-grand); 2016 Aug; 62(9):34-8. PubMed ID: 27585259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 mutation, allelism and survival in non-small cell lung cancer.
    Nelson HH; Wilkojmen M; Marsit CJ; Kelsey KT
    Carcinogenesis; 2005 Oct; 26(10):1770-3. PubMed ID: 15905205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer.
    Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C
    World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine homozygosity in codon 72 of p53 correlates with failure to imatinib response in chronic myeloid leukemia.
    Camelo-Santos J; do Prado Barbosa A; de Paula Silveira-Lacerda E; Guillo LA
    Biomed Pharmacother; 2013 Mar; 67(2):103-7. PubMed ID: 23433851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
    Jiang P; Liu J; Zeng X; Li W; Tang J
    Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development.
    Volodko N; Salla M; Eksteen B; Fedorak RN; Huynh HQ; Baksh S
    World J Gastroenterol; 2015 Sep; 21(36):10358-66. PubMed ID: 26420962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.
    Lai KC; Chen WC; Tsai FJ; Li SY; Jeng LB
    Hepatogastroenterology; 2005; 52(63):944-8. PubMed ID: 15966238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of nucleotide variants of TP53 and their correlation with the expression of p53 and its downstream proteins in a Sri Lankan cohort of breast and colorectal cancer patients.
    Manoharan V; Karunanayake EH; Tennekoon KH; De Silva S; Imthikab AIA; De Silva K; Angunawela P; Vishwakula S; Lunec J
    BMC Cancer; 2020 Jan; 20(1):72. PubMed ID: 32000721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women.
    Khadang B; Fattahi MJ; Talei A; Dehaghani AS; Ghaderi A
    Cancer Genet Cytogenet; 2007 Feb; 173(1):38-42. PubMed ID: 17284368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic polymorphism in codon 72 of p53 gene: prognosis value, survival rates, and their association with breast cancer.
    Golmohammadi R; Namazi MJ
    Eur J Gynaecol Oncol; 2016 Aug; 37(4):493-498. PubMed ID: 29894073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.